Full Course Description

Geriatric Pharmacology Intensive Training: Current Guidelines & Treatments for Older Adult Patients

To ensure positive outcomes and adequate health maintenance in the older adult person, it is important to continually review, update and clarify the role of geriatric pharmacology, pharmacokinetics, and pharmacodynamics as it pertains to each body system. Practical application and an intense case review Bring real-life patient care to the forefront 

Program Information


  1. Explore the pearls and pitfalls of both prescribed and over the counter medication regimens. 
  2. Analyze geriatric polypharmacy and how a multidisciplinary approach can mitigate medication use. 
  3. Determine effective education and communication strategies to use with patients and their families about common side effects from prescribed medications. 
  4. Plan for the most common challenging geriatric behaviors triggered by important drug to drug interactions. 
  5. Discover cultural barriers to patient medication compliance. 
  6. Identify over the counter medication risk. 
  7. Understand techniques to properly triage a medication list for the patient with multiple comorbidities. 
  8. Manage the use of the remote medication Pyxis. 
  9. Learn tips to improve collaboration with the pharmacist in your organization. 


Upper Gastrointestinal Conditions: Current Medication Guidelines & Treatments for Older Adults 

  • GERD 
    • Approach to the older adult with dyspepsia 
    • Medication induced esophagitis 
  • Constipation 
    • Opioid induced constipation 
  • Decreased Appetite/Failure to Thrive 
    • Discerning root causes 
    • Cachexia in Terminal Illness 
    • Dysphagia 
    • Dentition, Depression, Distaste 
  • Avoiding the GI Bleed  
    • Over the counter conundrum 
    • Anticoagulants - the risk vs. benefit 

Lower Gastrointestinal Conditions: Current Medication Guidelines & Treatments for Older Adults 

  • Small Bowel Obstruction 
    • Post op interventions 
    • Pathophysiology of GI peristalsis 
  • Diverticulitis vs. Diverticulosis 
  • Decreased Peristalsis 
  • Hemorrhoids 
  • Colon Cancer Risk and Updated Maintenance Guidelines 
  • Ulcerative Colitis /Crohn's Disease  
    • Role of autoimmune disease and the additional variable immunosuppression risk 

Pulmonology Conditions: Current Medication Guidelines & Treatments for Older Adults 

  • COPD  
    • Assessing risk/morbidity/mortality 
  • DVT Prophylaxis/Pulmonary Embolism  
    • Risk stratification for stroke risk - especially in patients with afib 
  • The Covid Long Hauler & Pulmonary Function 
    • Pulmonary rehab 
    • Where are we now? 
  • Smoking Cessation & the Older Adult Person 
  • Pneumonia 

Cardiology Conditions: Current Medication Guidelines & Treatments for Older Adults 

  • The Role of Aspirin 
  • Cardiac Arrhythmias - and the EKG rhythm 
  • Anticoagulation 
  • Anti-arrhythmics 
  • Antiplatelets 
  • Anti-hypertensives & Rate Control 
  • CHF 

Neurology Conditions: Current Medication Guidelines & Treatments for Older Adults 

  • Preserve Cognitive Function in the Dementia Patient 
  • Deprescribing to Avoid Polypharmacy Risks 
  • Neuroleptics and Central Nervous System Agents 
  • Dementia  
  • Behavioral Medications for: Sun Downing Aggression, Hallucinations, Hygiene, Intimacy, Anxiety, Repetitive and Depressive Behaviors, Nutrition 

Endocrine Conditions: Current Medication Guidelines & Treatments for Older Adults 

  • Diabetic Protocols & Medication Guidelines 
  • Management of Diabetic Emergencies 
  • Electrolyte Imbalance Role in Maintenance of Blood Glucose 
  • Hyperglycemia and Hypoglycemia in the Patient with Decreased PO Intake  
  • Musculoskeletal Conditions: Current Medication Guidelines & Treatments for Older Adult 

Musculoskeletal Complaints in Patients with Multiple Comorbidities  

  • Avoid the Pitfalls of End Organ Damage During Treatment 
  • Explore Topicals, Nutraceuticals & Other Related Adjuvants

Target Audience

  • Nurse Practitioners
  • Advanced Practice Nurses
  • Clinical Nurse Specialists
  • Physician Assistants
  • Pharmacists
  • Physicians
  • Nurses 

Copyright : 10/25/2023

Geriatric Pharmacology: Provide Optimal Pharmacotherapy

In the United States those over the age of 85 use a large amount of medical resources including medications. Sequelae from medication usage are common in the elderly and may result in hospitalizations and/or death. This Pharmacy lecture will provide you with the necessary tools to carefully monitor your patients medications and provide optimal pharmacotherapy. We will explore drug/drug and drug/disease scenarios. We will create a plan that will minimize the number of meds one needs to take and maximize the drug's side effect profile to our advantage. We will understand the importance of knowing the BEERS list. Upon completion of these pharmacy lectures you will feel more comfortable with medication management in older adults.

Program Information


  1. Define the terms polypharmacy and prescribing/medication cascade.
  2. Describe the elements of a thorough medication history and reconciliation.
  3. Identify prescription and over the counter risk of drug interactions.
  4. Utilize the BEERS criteria to identify potentially inappropriate medications in the older adult.
  5. Identify common medications that may affect current/future disease states.


What is polypharmacy?

  • Who is at risk?
  • What are the causes?
  • Prescribing Cascade
What is the BEERS list?
  • The American Geriatric Society Beers Criteria
  • What is on the Beers list?
What are drug interactions
  • Drug-drug interactions
  • Drug-food/beverage interactions
Drug-disease interactions
  • How do drug interactions occur?
A pharmacodynamic interaction
  • Why is it important to check for interaction?
  • Do drug interactions occur often?
  • Other factors causing drug interactions?
  • How do I check for drug interactions?
  • What should I do if I find a drug interaction?

Target Audience

  • Nurse Practitioners
  • Advance Practice Registered Nurses
  • Nurses
  • Physician Assistants
  • Occupational Therapists
  • Physical Therapists
  • Speech Language Pathologists
  • Nursing Home Administrators
  • Social Workers

Copyright : 09/29/2023

Pharmacology in the Older Adult

Older adults are a unique subset of patients that required customization of medications. In this session, we will take a deep dive into issues in geriatric pharmacology. Eric will explore the physiological differences of the older adult, the perils of polypharmacy and the prescription cascade, BEERS criteria, deprescribing, and other topics that are important in understanding medications in the older adult. Also included will be information about drug interactions, including over the counter medications, high risk medications, and high risk drug-disease interactions.

Program Information


  1. Identify physiological differences of the older adult and how that impacts medication management.
  2. Recognize potentially inappropriate and high-risk medications in the geriatric patient utilizing the Beers criteria.
  3. Discuss the risks of polypharmacy and the prescribing cascade.
  4. Identify common drug interactions with over-the-counter medications that will negatively impact our geriatric patients.


  • Physiological differences of the older adult
  • Perils of polypharmacy and the prescription cascade
    • BEERS criteria
    • Deprescribing
  • Drug interactions
    • Over the counter medications
  • High risk medications
    • High risk drug-disease interaction

Target Audience

  • Nurses
  • Nurse Practitioners
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Physical Therapists
  • Physical Therapist Assistants
  • Physician Assistants
  • Speech Language Pathologists
  • Other Healthcare Professionals

Copyright : 09/29/2022

Geriatric Psychopharmacology Updates & Trends

Are you a busy clinician who does not have time to keep up with the latest medications and trends in geriatric prescribing? This seminar will provide you with the information you need to feel more confident in choosing the right medication for your older adult patients with mental health issues and dementia. Join me, Dr. Tamatha Arms, PhD, DNP, PMHNP-BC, NP-C, as I discuss the newest recommendations from the American Geriatrics Society and the American Psychiatric Association and review the new neuropsychiatric medications available.  We are also learning that COVID-19 has been linked to long-term effects on the neurological system, causing delirium after recovery. Learn the latest indications for recognizing this condition and medication management options.

Program Information


  1. Apply principles of deprescribing anticholinergics. 
  2. Differentiate options for use of anxiolytics. 
  3. Diagnose and treat COVID related delirium. 
  4. Assess common drug interactions for dementia drugs. 
  5. Choose the optimum treatment for late life depression. 
  6. Analyze and prescribe the appropriate new neuropsychiatric medications. 




Delirium from COVID

  • Management with psychopharmacology 

Dementia drugs and common drug interactions  

Best strategies for use of antidepressants in older adults 


  • Brexpiprazole
  • Lumateperone
  • Lybalvi
  • Cariprazine
  • Lurasidone 


  • Esketamine 

Sleep disorders

  • Pitolisant
  • Lemborexant
  • Vortioxetine hydrobromide 


  • Istradefylline
  • Pimavanserin
  • Apomorphine HCL 


  • Aducanumab 

Tardive dyskinesia

  • Deutetrabenozine 

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants
  • Physicians
  • Physical Therapists
  • Physical Therapist Assistants
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Speech Language Pathologists
  • Social Workers
  • Nursing Home Administrators

Copyright : 09/21/2021

Pharmacology of Infectious Diseases & Immunizations for Advance Practice Clinicians

Attend this seminar and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.  

You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics, and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. You will leave this seminar better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes. 

Program Information


  1. Develop antibiotic recommendations in response to microbiologic testing results. 
  2. Describe clinical scenarios compelling for empiric coverage of resistant bacteria. 
  3. Discriminate clinical scenarios requiring initiation of antibiotics. 
  4. Integrate cephalosporins for successful management of complicated urinary tract infections.  
  5. Choose appropriate risk factor–based empiric antibiotic regimens for acute infections. 
  6. Recognize clinical scenarios necessitating avoidance of specific antibiotics based on side effect profiles. 
  7. Identify clinical situations appropriate for newly approved antimicrobials. 
  8. Formulate effective evidence-based treatment regimens for simple cystitis. 


Considerations for Successful Empiric Therapy 

  • Spectrum of activity for commonly used antibiotics 
  • Normal flora for infectious sites 
  • Resistance associated with common bacteria 
  • Pharmacodynamic influences on antibiotic dosing 

Interpretation of Microbiologic Test Results  

  • Gram stain results 
  • Culture and sensitivity results 
  • Minimum inhibitory concentration (MIC) evaluation 
  • PCR results 

Antibacterial Resistance 

  • Trends 
  • Mechanisms of resistance 
  • Contributing factors 
  • Antibiotic stewardship concepts 

Antibiotic Related Allergies– Penicillin and ‘Sulfa’ 

  • Define true allergy versus side effect 
  • Penicillin allergy and cephalosporin cross sensitivity  
  • ‘Sulfa’ allergy 

Skin and Soft Tissue Infections 

  • Streptococcus pyogenes vs. MRSA 
  • Review evidence for antibiotic management 
  • Review IDSA treatment guidelines 
  • Vancomycin AUC/MIC monitoring 


  • Review evidence for pathogen etiology 
  • Review evidence for antibiotic management 
  • IDSA/ATS community-acquired pneumonia treatment guidelines 
  • Resistance risk factors and management 
  • Review new antibiotics for MDR infections 


  • Review evidence for vaccine timing and use in older adults 
  • Review of clinical trial data for therapeutics 
  • Review IDSA/CDC treatment guidelines 

Urinary Tract Infections 

  • Review evidence for resistance trends 
  • Review of clinical trial data for therapeutics 
  • Antibiotics for MDR infections 
  • Clostridium Difficile Infection 

Risk factor evidence review 

  • Compare antibiotic risk levels 
  • Review IDSA treatment guidelines 
  • Review of clinical trial data for therapeutics 
  • Probiotics prophylaxis evidence review 

Target Audience

  • Nurse Practitioners
  • Advanced Practice Nurses
  • Clinical Nurse Specialists
  • Physician Assistants
  • Pharmacists
  • Physicians
  • Nurses 

Copyright : 10/26/2023

Gastrointestinal Pharmacology Update: Prescribing for Patient Outcome Achievement

Watch double certified Clinical Gastroenterologist Dr Peter Buch, as he provides solutions to your most challenging GI-related challenges in practice.  Focusing on common patient concerns, including H pylori, c difficile, inflammatory bowel disease and chronic constipation, you will take away the latest pharmacologic best practice insights to guide your own prescriptive decisions.

Program Information


  1. Determine the current best medication practices for H pylori.
  2. Select up-to-date approaches to manage chronic constipation.
  3. Analyze the best pharmacological strategies for PPI use.
  4. Explore important updates in clostridium difficile treatment.
  5. Plan to incorporate the newest strategies for successful treatment of Inflammatory Bowel Disease.


Helicobacter Pylori

  • Testing regimens
  • Clarithromycin resistance and need for quadruple therapy
  • Pill burden and risk of recurrence
  • How to manage refractory H pylori
Proton pump inhibitors (PPIs)
  • Who needs chronic therapy
  • REAL side effects of PPIs
Clostridium Difficile
  • Should we still be using Metronidazole?
  • Vancomycin
  • Fidaxomicin
  • Fecal transplants - the ultimate probiotic
  • Bezlotoxumab
Inflammatory Bowel Disease
  • When to consider 5 ASAs
  • Antibiotics
  • Steroids
  • Antimetabolites
  • Anti TNFs
  • Vedolizumab
  • Ustekinumab
  • Tofacitiniub
  • Biosimilars
Opioid Induced Constipation
  • How to choose among: Osmotic or stimulant laxatives
  • PAMORAS: Naloxegol,Naldemedine, Methylnaltrexone
  • Secretogogues like Lubiprostone
  • Selective 5HT4 agonist like Prucalopride

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physicians Assistants

Copyright : 03/24/2022

Parkinson’s Disease: Current Pharmacologic Methods of Treatment

Parkinson disease is a heterogeneous disease with rapidly and slowly progressive forms. Treatment involves pharmacologic approaches (typically with levodopa preparations prescribed with or without other medications) and nonpharmacologic approaches (such as exercise and physical, occupational, and speech therapies). Our emphasis in this training session will be on current evidence to guide medication selection. Approaches such as deep brain stimulation and treatment with levodopa-carbidopa enteral suspension can help individuals with medication-resistance tremor, worsening symptoms when the medication wears off, and dyskinesias.

Program Information


  1. Develop a predication model for diagnosis of Parkinson’s Disease based on presentations in primary care.
  2. Describe the current treatment options of Parkinson’s Disease.
  3. Analyze nonpharmacologic and pharmacologic methods of treatment of Parkinson’s.
  4. Evaluate deep brain stimulation and treatment with levodopa-carbidopa enteral suspension to help individuals with medication-resistant tremor, worsening symptoms when the medication wears off, and dyskinesias.


Clinical Significance

  • Defined primarily by motor symptoms including tremor, bradykinesia and akinesia
  • May demonstrate non-motor symptoms such as cognitive decline, depression, anxiety, sleep disturbance and dysautonomia
  • Dopaminergic medications and deep brain stimulation for motor symptom treatment
Clinical Presentation to Guide Pharmacological Decisions
  • Assessment
  • Imaging
  • Co-morbidities
Evidence Based Treatments
  • Medications
  • Nonpharmacy
  • Surgeries
  • Rehab

Copyright : 04/20/2023

Dementia: New & Improving Treatments

Alzheimer’s disease, and other dementia types, can profoundly impact the lives of those who suffer from it.  Compared to older treatments, which only targeted symptoms, the newest treatment options for Alzheimer's now target the underlying pathological disease process. Expert geriatric clinician, Steven Atkinson, PA-C, MS, will provide clear updates to immediately make a difference for the dementia patients you treat!

Program Information


  1. Select the best drug choices based on dementia type.
  2. Determine the tools to help in the diagnosis of common dementia types.
  3. Analyze CMS treatment coverage policies.
  4. Evaluate common pharmacological treatments for behaviors.
  5. Identify medications to avoid when prescribing for dementia patients.


  • Drug Utilization Amongst the Elderly
  • Ruling out Delirium and Depression
    • Approaches to Delirium
    • Approaches to Depression
  • Anticholinergic Burden in the Elderly
  • Cognitive Screens
  • Artificial Intelligence
  • Dementia Types
    • SDAT
      • Imaging
      • The biological definition
    • LATE-NC
    • Vascular Dementia
    • Dementia with Lewy Bodies
    • FTD
    • Substance-Induced Dementia
  • Traditional Pharmacological Treatments
    • ChI’s
    • Memantine
  • Newly Approved Alzheimer’s Medications
  • Depression in Dementia
  • Apathy in Dementia
  • Anxiety in Dementia
  • Sleep Disorders in Dementia
  • Weight Loss in Dementia
  • Differences that Make ALL the Difference
  • Beyond Drugs

Target Audience

  • Nurse Practitioners
  • Advance Practice Registered Nurses
  • Nurses
  • Physician Assistants
  • Occupational Therapists
  • Physical Therapists
  • Speech Language Pathologists
  • Nursing Home Administrators
  • Social Workers

Copyright : 09/28/2023